Acro Biomedical (ACBM) Other Gross PP&E Adjustments (2019 - 2025)
Acro Biomedical has reported Other Gross PP&E Adjustments over the past 7 years, most recently at -$13651.0 for Q2 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$13651.0 for Q2 2025, up 65.66% from a year ago — trailing twelve months through Jun 2025 was -$13651.0 (up 65.66% YoY), and the annual figure for FY2024 was -$26898.0, up 48.5%.
- Other Gross PP&E Adjustments for Q2 2025 was -$13651.0 at Acro Biomedical, up from -$20324.0 in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for ACBM hit a ceiling of -$6268.0 in Q3 2021 and a floor of -$52233.0 in Q4 2023.
- Median Other Gross PP&E Adjustments over the past 5 years was -$26308.5 (2022), compared with a mean of -$27734.6.
- Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 79.6% in 2023 and later plummeted 411.42% in 2024.
- Acro Biomedical's Other Gross PP&E Adjustments stood at -$50432.0 in 2021, then soared by 49.0% to -$25719.0 in 2022, then plummeted by 103.09% to -$52233.0 in 2023, then skyrocketed by 48.5% to -$26898.0 in 2024, then soared by 49.25% to -$13651.0 in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$13651.0 (Q2 2025), -$20324.0 (Q1 2025), and -$26898.0 (Q4 2024) per Business Quant data.